Armin Rabsteyn
Impact in
- Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- Immunology top 10%
- Immunotherapy and Immune Responses
- T-cell and B-cell Immunology
Papers in
- Immunology 11
- Immunotherapy and Immune Responses 6
- Immune Cell Function and Interaction 3
- Oncology 10
- Cancer Immunotherapy and Biomarkers 5
- CAR-T cell therapy research 3
- Co-authors
- Dennis Lindau (2 shared papers)Hans‐Georg Rammensee (2 shared papers)Patrice Decker (2 shared papers)Matthieu Ribon (1 shared paper)Ina Kötter (2 shared papers)Julie Mussard (1 shared paper)Gosse J. Adema (1 shared paper)Marie‐Christophe Boissier (1 shared paper)
- Journals
- Frontiers in Immunology (3 papers)Vaccines (3 papers)Annals of the Rheumatic Diseases (2 papers)Bone Marrow Transplantation (1 paper)Journal for ImmunoTherapy of Cancer (1 paper)
- Partner nations
- GermanyUnited StatesAustralia
In The Last Decade
Armin Rabsteyn
20 papers receiving 966 citations
Peers
Comparison fields: 5 of 70
- Infectious Diseases 379
- Immunology 392
- Oncology 207
- Neurology 94
- Molecular Biology 396
Countries citing papers authored by Armin Rabsteyn
This map shows the geographic impact of Armin Rabsteyn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Armin Rabsteyn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Armin Rabsteyn more than expected).
Fields of papers citing papers by Armin Rabsteyn
This network shows the impact of papers produced by Armin Rabsteyn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Armin Rabsteyn. The network helps show where Armin Rabsteyn may publish in the future.
Co-authors
The 25 scholars most cited alongside Armin Rabsteyn, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 443 | |
| 2 | 2017 | 139 | |
| 3 | 2015 | 112 | |
| 4 | 2013 | 80 | |
| 5 | 2024 | 39 | |
| 6 | 2017 | 38 | |
| 7 | 2021 | 35 | |
| 8 | 2019 | 33 | |
| 9 | 2021 | 13 | |
| 10 | 2020 | 13 | |
| 11 | 2022 | 10 | |
| 12 | 2023 | 7 | |
| 13 | 2019 | 6 | |
| 14 | 2024 | 3 | |
| 15 | 2025 | 3 | |
| 16 | 2024 | 1 | |
| 17 | 2011 | 1 | |
| 18 | 2024 | 1 | |
| 19 | 2025 | 1 | |
| 20 | 2025 | 1 |
About Armin Rabsteyn
Armin Rabsteyn is a scholar working on Immunology, Oncology, Hematology, Infectious Diseases and Genetics, having authored 22 papers that have together received 979 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (6 papers), Cancer Immunotherapy and Biomarkers (5 papers), COVID-19 Clinical Research Studies (4 papers), vaccines and immunoinformatics approaches (4 papers), Hematopoietic Stem Cell Transplantation (4 papers), CAR-T cell therapy research (3 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and Immune Cell Function and Interaction (3 papers). The work is most often cited by research in Infectious Diseases (379 citations), Immunology (392 citations), Oncology (207 citations), Neurology (94 citations) and Molecular Biology (396 citations). Armin Rabsteyn has collaborated with scholars based in Germany, United States and Australia. Frequent co-authors include Dennis Lindau, Hans‐Georg Rammensee, Patrice Decker, Matthieu Ribon, Ina Kötter, Julie Mussard, Gosse J. Adema, Marie‐Christophe Boissier, PETER J. LANG and Rupert Handgretinger. Their work appears in journals such as Frontiers in Immunology, Vaccines, Annals of the Rheumatic Diseases, Bone Marrow Transplantation and Journal for ImmunoTherapy of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.